Generate a tailored SOP for Dr. Charles De Bock. Improve your application with a focused, well-structured draft.
Dr. Charles de Bock is an Associate Professor at the University of New South Wales, specializing in molecular cellular biology with a focus on blood cancers, particularly T-cell acute lymphoblastic leukaemia (T-ALL). With over ten years of experience, his research aims to innovate targeted therapies that minimize long-term effects of aggressive chemotherapy on children. His previous work includes a position at the VIB-KU Leuven Center for Cancer Biology in Belgium, providing him with expertise in next-generation sequencing and genome editing technologies. As the Team Leader of the Functional Genomics Leukaemia Group, Dr. de Bock leads research to develop specialized mouse models to enhance understanding of T-ALL and assess the efficacy of new therapies. He has authored 59 peer-reviewed publications in high-impact journals and has been recognized with several awards, including the Haematology Society Australia New Zealand Mid-career award. Holding a Conjoint Senior Lecturer appointment at UNSW Sydney, Dr. de Bock is dedicated to translating research into clinical practice to improve patient outcomes.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.